Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
NICE has published 4 new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
As COVID-19 becomes more prevalent in the community, pneumonia is more likely to be caused by the COVID-19 virus than bacteria. Viral pneumonia will not respond to the use of antibiotics, therefore, they should only be offered if bacteria are the likely cause, it is unclear whether the cause is bacterial or viral and symptoms are more concerning or the person is at high risk of developing complications.
People should seek medical help without delay if their symptoms don’t improve or worsen rapidly, whether they have been given an antibiotic or not.
When possible, clinicians should discuss the risks, benefits and possible likely outcomes of treatment options with patients with COVID-19, and their families and carers, so that they can express their preferences about their treatment.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.